Biological Valves: The Growing Preference for Tissue-Based Heart Valve Replacement

0
2

When a heart valve can no longer function properly, replacement surgery becomes essential — and the choice between mechanical and biological valves is one of the most consequential decisions a patient faces. Biological valves, made from animal tissue (typically bovine pericardium or porcine valves), offer a compelling alternative to mechanical options because they typically do not require lifelong anticoagulation therapy. This advantage is driving strong and sustained demand in the global heart valve market.

The biological valve market encompasses surgical tissue valves, transcatheter heart valves (TAVR/TAVI), and related delivery systems and accessories. Growth is driven by the aging population, rising prevalence of valvular heart disease, and a clear shift in clinical preference toward tissue valves, particularly among older patients who face higher bleeding risks with anticoagulants. The rapid expansion of transcatheter aortic valve replacement has been a major catalyst, enabling treatment of patients who are not candidates for open surgery.

Technological innovation is improving durability and outcomes. Newer-generation tissue valves feature advanced anti-calcification treatments, improved hemodynamics, and better deliverability for transcatheter procedures. However, challenges remain, including limited valve durability in younger patients, high device costs, and complex regulatory pathways.

Despite these hurdles, the biological valve market is expected to grow robustly as aging demographics and minimally invasive techniques continue to reshape cardiac care.

People Also Ask

Q: What is a biological heart valve?
A: A biological valve is made from animal tissue, such as bovine pericardium or porcine valves, used to replace a damaged heart valve without requiring lifelong blood thinners.

Q: How long do biological heart valves last?
A: Biological valves typically last 10–20 years, depending on patient age, valve type, and other factors, with younger patients often experiencing faster degeneration.

Tags: #BiologicalValve #HeartValveReplacement #TAVR #TissueValves #CardiacSurgery #StructuralHeart

Поиск
Категории
Больше
Другое
The In Vitro Lung Model Market Playbook for Business Leaders
In Vitro Lung Model Market  According to the latest report published by Data Bridge Market...
От ROHITT 2026-07-31 07:18:48 0 312
Food
Pregnancy Snacks Market Trends: Market to Reach USD 2.6 Billion by 2036, FMI Says
NEWARK, Del., July 13, 2026 — The global Pregnancy Snacks Market is expected to witness...
От ajaymore 2026-07-13 19:51:41 0 486
Другое
Adhesive Tapes Market Set to Reach USD 138.4 Billion by 2036
August 29, 2026 — The global adhesive tapes market is expected to grow...
От Alexa 2026-08-29 05:19:09 0 501
Другое
Film Grade PLA Market Growth Fueled by Sustainable Packaging Demand
According to WiseGuy Reports, the Film Grade PLA Market was valued at USD 1,042.9 million in 2024...
От dineshhh_18 2026-07-27 11:37:18 0 588
Другое
Why Do Commercial Flat Roof Drainage Problems Develop, and How Can They Be Fixed?
Commercial buildings depend on a roof that can manage rainwater without allowing moisture to...
От Petter 2026-10-29 13:08:18 0 170